FI971274A0 - Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia - Google Patents

Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia

Info

Publication number
FI971274A0
FI971274A0 FI971274A FI971274A FI971274A0 FI 971274 A0 FI971274 A0 FI 971274A0 FI 971274 A FI971274 A FI 971274A FI 971274 A FI971274 A FI 971274A FI 971274 A0 FI971274 A0 FI 971274A0
Authority
FI
Finland
Prior art keywords
6alkyl
substituted
halo
hydrogen
alk
Prior art date
Application number
FI971274A
Other languages
English (en)
Swedish (sv)
Other versions
FI971274A (fi
FI119640B (fi
Inventor
Daele Georges Henri Paul Van
Jean-Paul Rene Marie A Bosmans
Den Keybus Frans Maria Alf Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI971274A publication Critical patent/FI971274A/fi
Publication of FI971274A0 publication Critical patent/FI971274A0/fi
Application granted granted Critical
Publication of FI119640B publication Critical patent/FI119640B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI971274A 1994-09-27 1997-03-26 Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia FI119640B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31
US45548695 1995-05-31
EP9503691 1995-09-19
PCT/EP1995/003691 WO1996010027A1 (en) 1994-09-27 1995-09-19 N-substituted piperidinyl bicyclic benzoate derivatives

Publications (3)

Publication Number Publication Date
FI971274A FI971274A (fi) 1997-03-26
FI971274A0 true FI971274A0 (fi) 1997-03-26
FI119640B FI119640B (fi) 2009-01-30

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971274A FI119640B (fi) 1994-09-27 1997-03-26 Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia

Country Status (23)

Country Link
EP (1) EP0784620B1 (fi)
JP (1) JP3953097B2 (fi)
CN (1) CN1068880C (fi)
AT (1) ATE187453T1 (fi)
AU (1) AU699152B2 (fi)
BR (1) BR9509036A (fi)
CA (1) CA2200578C (fi)
CZ (1) CZ289031B6 (fi)
DE (1) DE69513846T2 (fi)
DK (1) DK0784620T3 (fi)
ES (1) ES2141383T3 (fi)
FI (1) FI119640B (fi)
GR (1) GR3032646T3 (fi)
HU (1) HU218698B (fi)
IL (1) IL115413A (fi)
MY (1) MY113202A (fi)
NO (1) NO313238B1 (fi)
NZ (1) NZ293605A (fi)
PL (1) PL182502B1 (fi)
PT (1) PT784620E (fi)
RU (1) RU2154064C2 (fi)
WO (1) WO1996010027A1 (fi)
ZA (1) ZA958081B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058527A2 (en) * 1998-05-14 1999-11-18 EGIS Gyógyszergyár Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
CA2551171C (en) 2003-12-23 2012-07-10 Bio-Medisinsk Innovasjon As Modulators of peripheral 5-ht receptors
NZ551603A (en) 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
SI2395002T1 (sl) 2005-11-08 2014-10-30 Vertex Pharmaceuticals Incorporated Farmacevtski sestavek, vsebujoč heterociklični modulator prenašalcev z ATP-vezavno kaseto
JP5497633B2 (ja) 2007-05-09 2014-05-21 バーテックス ファーマシューティカルズ インコーポレイテッド Ｃｆｔｒのモジュレーター
WO2009073757A1 (en) 2007-12-07 2009-06-11 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
AU2008335440B2 (en) 2007-12-07 2013-11-07 Vertex Pharmaceuticals Incorporated Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
US8299099B2 (en) 2008-02-28 2012-10-30 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as CFTR modulators
WO2011127241A2 (en) 2010-04-07 2011-10-13 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
PL2555754T3 (pl) * 2010-04-07 2016-09-30 Formy stałe kwasu 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-ilo)cyklopropanokarboksyamido)-3-metylopirydyn-2-ylo)benzoesowego
WO2015073231A1 (en) 2013-11-12 2015-05-21 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
WO2016081556A1 (en) 2014-11-18 2016-05-26 Vertex Pharmaceuticals Incorporated Process of conducting high throughput testing high performance liquid chromatography

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
RU2154064C2 (ru) 2000-08-10
GR3032646T3 (en) 2000-06-30
HU218698B (hu) 2000-11-28
NZ293605A (en) 1998-07-28
ES2141383T3 (es) 2000-03-16
NO971376D0 (no) 1997-03-24
MY113202A (en) 2001-12-31
IL115413A0 (en) 1995-12-31
NO971376L (no) 1997-05-05
NO313238B1 (no) 2002-09-02
JP3953097B2 (ja) 2007-08-01
FI971274A (fi) 1997-03-26
CN1166171A (zh) 1997-11-26
HUT77173A (hu) 1998-03-02
BR9509036A (pt) 1997-10-14
IL115413A (en) 2000-02-17
ATE187453T1 (de) 1999-12-15
CA2200578A1 (en) 1996-04-04
EP0784620A1 (en) 1997-07-23
ZA958081B (en) 1997-03-26
CN1068880C (zh) 2001-07-25
AU3608195A (en) 1996-04-19
PL319997A1 (en) 1997-09-01
DE69513846D1 (de) 2000-01-13
FI119640B (fi) 2009-01-30
WO1996010027A1 (en) 1996-04-04
PT784620E (pt) 2000-05-31
CZ91897A3 (en) 1997-12-17
PL182502B1 (pl) 2002-01-31
DE69513846T2 (de) 2000-07-06
CZ289031B6 (cs) 2001-10-17
CA2200578C (en) 2006-11-07
AU699152B2 (en) 1998-11-26
MX9702363A (es) 1997-10-31
EP0784620B1 (en) 1999-12-08
JPH10506118A (ja) 1998-06-16
DK0784620T3 (da) 2000-05-22

Similar Documents

Publication Publication Date Title
DE69513846D1 (de) N-substituierte piperidinyl bicyclische benzoatderivate
ES449191A1 (es) Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina.
TW369526B (en) Diazabicyclic neurokinin antagonists
DE69633607D1 (de) Piperidinderivate mit tachykinin-antagonistischer wirkung
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
DE69921994D1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
ATE171943T1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
TW360653B (en) A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
NO20045494L (no) 2,4-dihydroksybenzosyre-derivater
ATE178064T1 (de) Phenyl-oxo-alkyl-(4-piperidinyl) benzoatderivate
JO1648B1 (en) Nitrogen compounds
JO1697B1 (en) Pyridine derivatives
NO932513L (no) N-alkyl-kinuklidinium-salter